Alkermes plc (NASDAQ: ALKS) is 5.59% higher on its value in year-to-date trading and has touched a low of $21.75 and a high of $32.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ALKS stock was last observed hovering at around $28.37 in the last trading session, with the day’s gains setting it 0.92%.
Currently trading at $29.29, the stock is 6.45% and 6.01% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.27 million and changing 3.24% at the moment leaves the stock 10.41% off its SMA200. ALKS registered 26.08% gain for a year compared to 6-month gain of 21.54%. The firm has a 50-day simple moving average (SMA 50) of $27.6068 and a 200-day simple moving average (SMA200) of $26.5245.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 8.04% loss in the last 1 month and extending the period to 3 months gives it a 9.50%, and is 11.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.28% over the week and 3.43% over the month.
Alkermes plc (ALKS) has around 2100 employees, a market worth around $4.74B and $1.51B in sales. Current P/E ratio is 14.92 and Fwd P/E is 15.91. Profit margin for the company is 22.15%. Distance from 52-week low is 34.65% and -10.92% from its 52-week high. The company has generated returns on investments over the last 12 months (20.22%).
The EPS is expected to grow by 82.69% this year
461.0 institutions hold shares in Alkermes plc (ALKS), with institutional investors hold 114.94% of the company’s shares. The shares outstanding are 166.98M, and float is at 158.76M with Short Float at 9.97%. Institutions hold 113.41% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 29.11 million shares valued at $701.49 million. The investor’s holdings represent 17.3276 of the ALKS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 20.0 million shares valued at $482.0 million to account for 11.9058 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 14.35 million shares representing 8.5453 and valued at over $345.95 million, while PRICE T ROWE ASSOCIATES INC /MD/ holds 6.5556 of the shares totaling 11.01 million with a market value of $265.4 million.
Alkermes plc (ALKS) Insider Activity
The most recent transaction is an insider sale by Hopkinson Craig C., the company’s EVP R&D, Chief Medical Officer. SEC filings show that Hopkinson Craig C. sold 10,471 shares of the company’s common stock on Nov 06 ’24 at a price of $29.53 per share for a total of $0.31 million. Following the sale, the insider now owns 99238.0 shares.
Still, SEC filings show that on Mar 18 ’24, Nichols Christian Todd (SVP, Chief Commercial Officer) disposed off 10,417 shares at an average price of $28.10 for $0.29 million. The insider now directly holds 65,911 shares of Alkermes plc (ALKS).
